Loading…
UTROGESTAN is a brand name for Progesterone, supplied as a capsule. The medicine, its uses, side effects and dosage are the same regardless of brand.
Verbatim from this product's HC label. Tap a section to expand.
4 Geriatrics 2026-04 Certain sections or subsections that are not applicable at the time of the preparation of the most recent authorized product monograph are not listed. Table of Contents Recent Major Label Changes...................................................................................................
2 Table of Contents ................................................................................................................... 2 Part 1: Healthcare Professional Information ...........................................................................
4 1. Indications ....................................................................................................................... 1. 2. 4 2. Contraindications ............................................................................................................
4 4. Dosage and Administration ............................................................................................. 2. 4. 5. 4 5. Overdose .........................................................................................................................
5 6. Dosage Forms, Strengths, Composition, and Packaging ................................................... 5 7. Warnings and Precautions ...............................................................................................
1. 1. Pregnancy ........................................................................................................ 2. Breastfeeding ..................................................................................................
3. Pediatrics ......................................................................................................... 4. Geriatrics .........................................................................................................
7 8. Adverse Reactions ........................................................................................................... 1. 2. 1. Clinical Trial Adverse Reactions – Pediatrics ....................................................
5. 9 9. Drug Interactions ............................................................................................................. 3. 4. 7. 12 10. Clinical Pharmacology ...................................................................................................
1. 3. 13 11. Storage, Stability, and Disposal ...................................................................................... 14 Part 2: Scientific Information ................................................................................................
15 13. Pharmaceutical Information .......................................................................................... 15 14. Clinical Trials..................................................................................................................
4 Geriatrics 2026-04 Certain sections or subsections that are not applicable at the time of the preparation of the most recent authorized product monograph are not listed. Table of Contents Recent Major Label Changes...................................................................................................
2 Table of Contents ................................................................................................................... 2 Part 1: Healthcare Professional Information ...........................................................................
4 1. Indications ....................................................................................................................... 1. 2. 4 2. Contraindications ............................................................................................................
4 4. Dosage and Administration ............................................................................................. 2. 4. 5. 4 5. Overdose .........................................................................................................................
5 6. Dosage Forms, Strengths, Composition, and Packaging ................................................... 5 7. Warnings and Precautions ...............................................................................................
1. 1. Pregnancy ........................................................................................................ 2. Breastfeeding ..................................................................................................
3. Pediatrics ......................................................................................................... 4. Geriatrics .........................................................................................................
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Progesterone in Canada.
Know a brand we are missing in Canada? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
1. 15 16. Non-Clinical Toxicology .................................................................................................. 18 Patient Medication Information ...........................................................................................
20 UTROGESTAN Product Monograph Page 4 of 24 Part 1: Healthcare Professional Information 1. 1. 2.
Geriatrics Geriatrics (>65 years of age):
No clinical data have been collected in patients over age 65. 2. Contraindications UTROGESTAN should not be used in individuals with any of the following conditions: • Hypersensitive to progesterone, soya lecithin, gelatin or to any other ingredient in the formulation, including any non-medicinal ingredient, or component of the container.
For a complete listing, see 6. Dosage Forms, […]
7 8. Adverse Reactions ........................................................................................................... 1. 2. 1. Clinical Trial Adverse Reactions – Pediatrics ....................................................
5. 9 9. Drug Interactions ............................................................................................................. 3. 4. 7. 12 10. Clinical Pharmacology ...................................................................................................
1. 3. 13 11. Storage, Stability, and Disposal ...................................................................................... 14 Part 2: Scientific Information ................................................................................................
15 13. Pharmaceutical Information .......................................................................................... 15 14. Clinical Trials..................................................................................................................
1. 15 16. Non-Clinical Toxicology .................................................................................................. 18 Patient Medication Information ...........................................................................................
20 UTROGESTAN Product Monograph Page 4 of 24 Part 1: Healthcare Professional Information 1. 1. 2.
Geriatrics Geriatrics (>65 years of age):
No clinical data have been collected in patients over age 65. 2. Contraindications UTROGESTAN should not be used in individuals with any of the following conditions: • Hypersensitive to progesterone, soya lecithin, gelatin or to any other ingredient in the formulation, including any non-medicinal ingredient, or component of the container.
For a […]